Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art
{{output}}
Background: Breast cancer (BC) is a biologically heterogeneous disease, and no single imaging modality captures the full spectrum of phenotypes across all stages of the disease. This review summarizes advances in receptor-targete... ...
